113 related articles for article (PubMed ID: 8393501)
21. The role of monoclonal antibody A7 as a drug modifier in cancer therapy.
Kitamura K; Miyagaki T; Yamaoka N; Tsurumi H; Noguchi A; Yamaguchi T; Takahashi T
Cancer Immunol Immunother; 1993; 36(3):177-84. PubMed ID: 8439978
[TBL] [Abstract][Full Text] [Related]
22. Targeted chemotherapy in mice with peritoneally disseminated gastric cancer using monoclonal antibody-drug conjugate.
Okamoto K; Yamaguchi T; Otsuji E; Yamaoka N; Yata Y; Tsuruta H; Kitamura K; Takahashi T
Cancer Lett; 1998 Jan; 122(1-2):231-6. PubMed ID: 9464516
[TBL] [Abstract][Full Text] [Related]
23. In vivo efficacy of neocarzinostatin coupled with Fab human/mouse chimeric monoclonal antibody A7 against human colorectal cancer.
Yamaguchi T; Tsurumi H; Kotani T; Yamaoka N; Otsuji E; Kitamura K; Takahashi T
Jpn J Cancer Res; 1994 Feb; 85(2):167-71. PubMed ID: 8144398
[TBL] [Abstract][Full Text] [Related]
24. Biodistribution of monoclonal antibody A7 and its F(ab')2 fragment in athymic nude mice bearing human pancreatic carcinoma.
Otsuji E; Yamaguchi T; Yamaoka N; Yamaguchi N; Imanishi J; Takahashi T
J Surg Oncol; 1992 Jul; 50(3):173-8. PubMed ID: 1619940
[TBL] [Abstract][Full Text] [Related]
25. Potential usefulness of 99mTc-labeled monoclonal antibody A7 for immunoscintigraphy of human pancreatic carcinoma.
Matsumura H; Otsuji E; Kobayashi S; Okamoto K; Toma A; Yamagishi H
Anticancer Res; 2001; 21(5):3433-7. PubMed ID: 11848505
[TBL] [Abstract][Full Text] [Related]
26. Binding, internalization and the cytotoxicity of monoclonal antibody A7-neocarzinostatin conjugates (A7-NCS) in target cells.
Kitamura K; Takahashi T; Noguchi A; Takashina K; Tsurumi H; Yamaguchi T
Tohoku J Exp Med; 1990 Jul; 161(3):199-207. PubMed ID: 2147302
[TBL] [Abstract][Full Text] [Related]
27. Biodistribution of murine and chimeric Fab fragments of the monoclonal antibody A7 in human pancreatic cancer.
Otsuji E; Yamaguchi T; Yamaoka N; Kotani T; Kato M; Taniguchi K; Kiyamura K; Takahashi T
Pancreas; 1995 Apr; 10(3):265-73. PubMed ID: 7624304
[TBL] [Abstract][Full Text] [Related]
28. Decreased production of anti-mouse antibody after administration of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate to human.
Yata Y; Otsuji E; Okamoto K; Tsuruta H; Kobayashi S; Toma A; Yamagishi H
Hepatogastroenterology; 2003; 50(49):80-4. PubMed ID: 12629996
[TBL] [Abstract][Full Text] [Related]
29. Production, binding and cytotoxicity of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate.
Yamaguchi T; Tsurumi H; Kitamura K; Otsuji E; Miyagaki T; Kotani T; Takahashi T
Jpn J Cancer Res; 1993 Nov; 84(11):1190-4. PubMed ID: 8276723
[TBL] [Abstract][Full Text] [Related]
30. [Intratumoral administration of monoclonal antibody-drug conjugate for treatment of pancreatic cancer].
Otsuji E; Yamaguchi T; Matsumura H; Nishida T; Yamamoto K; Tsuruta H; Okamoto K; Yata Y; Kitamura K; Takahashi T
Gan To Kagaku Ryoho; 1998 Jan; 25(1):135-7. PubMed ID: 9464341
[No Abstract] [Full Text] [Related]
31. [Clinical application of monoclonal antibody-drug conjugates in colorectal carcinoma].
Takahashi T; Sakita M; Yamaguchi T; Kitamura K; Hata K; Noguchi A
Gan To Kagaku Ryoho; 1988 May; 15(5):1702-9. PubMed ID: 2967049
[TBL] [Abstract][Full Text] [Related]
32. [Targeting chemotherapy of colorectal cancer by monoclonal antibody conjugated antitumor drug].
Yamaguchi T; Takahashi T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1060-4. PubMed ID: 2968778
[TBL] [Abstract][Full Text] [Related]
33. Changes in expression of the antigen recognized by monoclonal antibody A7 in human pancreatic carcinoma cells following exposure to anticancer agents.
Yamaguchi T; Yamaoka N; Kitamura K; Otsuji E; Okamoto K; Tsuruta H; Yata Y; Takahashi T
Cancer Lett; 1998 Apr; 126(2):165-72. PubMed ID: 9585062
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody-drug conjugate therapy for the patients with colorectal cancer.
Takahashi T; Yamaguchi T; Kitamura K; Noguchi A; Honda M
Tohoku J Exp Med; 1992 Oct; 168(2):371-4. PubMed ID: 1306322
[TBL] [Abstract][Full Text] [Related]
35. [Missile therapy using monoclonal antibody drug conjugates in colorectal carcinoma].
Takahashi T; Yamaguchi T; Yokota T; Kitamura K; Suzuyama H; Honda M; Otsuji E; Sawai K; Sakita M; Kotanagi H
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):931-7. PubMed ID: 2952068
[TBL] [Abstract][Full Text] [Related]
36. [Application of chimeric Fab fragments of monoclonal antibody A7 for targeting chemotherapy against pancreatic cancer].
Otsuji E; Yamaguchi T; Matsumura H; Nishida T; Yamamoto K; Tsuruta H; Okamoto K; Yata Y; Kitamura K; Takahashi T
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2285-7. PubMed ID: 9422075
[No Abstract] [Full Text] [Related]
37. Comparative pharmacokinetic properties of murine monoclonal antibody A7 modified with neocarzinostatin, dextran and polyethylene glycol.
Takashina K; Kitamura K; Yamaguchi T; Noguchi A; Noguchi A; Tsurumi H; Takahashi T
Jpn J Cancer Res; 1991 Oct; 82(10):1145-50. PubMed ID: 1720116
[TBL] [Abstract][Full Text] [Related]
38. [Increased effect of neocarzinostatin bound to chimeric Fab fragments of monoclonal antibody A7 on the proliferation of human pancreatic carcinoma].
Otsuji E; Kobayashi S; Nishida T; Yamamoto K; Matsumura H; Ichikawa D; Okamoto K; Shirasu M; Sakakura C; Kitamura K; Yamaguchi T
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1775-7. PubMed ID: 9757206
[No Abstract] [Full Text] [Related]
39. Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy.
Kitamura K; Takahashi T; Yamaguchi T; Noguchi A; Noguchi A; Takashina K; Tsurumi H; Inagake M; Toyokuni T; Hakomori S
Cancer Res; 1991 Aug; 51(16):4310-5. PubMed ID: 1868453
[TBL] [Abstract][Full Text] [Related]
40. Optimal timing of administration of hyperthermia in combined radioimmunotherapy.
Kinuya S; Yokoyama K; Hiramatsu T; Konishi S; Watanabe N; Shuke N; Aburano T; Bunko H; Michigishi T; Tonami N
Cancer Biother Radiopharm; 2000 Aug; 15(4):373-9. PubMed ID: 11041022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
